Skip to content

Factors Influencing Cancer Patients Participation in Clinical Trials in China.

Assessing Knowledge and Affecting Factors Associated With Cancer Patients Participation in Clinical Trials in China.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03412344
Enrollment
300
Registered
2018-01-26
Start date
2017-07-15
Completion date
2018-12-31
Last updated
2018-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

clinical trial, patient, questionnaire

Brief summary

This research studies factors affecting Chinese patient participation in cancer clinical trials and their knowledge regarding clinical trials. The investigators design this study to determining how patients makes decisions about participating in a clinical trial and know about patients' attitude toward clinical trials. The investigators aim to find ways to make cancer clinical trials in China more efficient and satisfied patients participating in clinical trials in China.

Interventions

None listed

Sponsors

Chinese Academy of Medical Sciences
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years

Inclusion criteria

* Clinical diagnosis of malignancy * Aged 18 years or older * Ability to understand and complete the questionnaire independently or with the help of a relative or staff member of the oncology department * Patients have been consented to join an oncology treatment clinical study and have begun active treatment of an oncology clinical trial

Exclusion criteria

• Not meeting all eligibility criteria

Design outcomes

Primary

MeasureTime frame
The patient related factors and the doctor related factors that influence patient decision regarding participation in a cancer clinical trial will be explored by questionnaire.1 year

Secondary

MeasureTime frame
Oncology patients' understanding and attitude of clinical trials towards cancer clinical research will be evaluated by questionnaire.1 year
The actual experience of participants in a cancer clinical trial will be investigated by questionnaire.1 year

Countries

China

Contacts

Primary ContactShiyu Jiang, MD
309615685@qq.com+86 13121700970

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026